HCA Healthcare (NYSE:HCA) had its price target hoisted by research analysts at BMO Capital Markets from $96.00 to $115.00 in a research report issued to clients and investors on Thursday. The brokerage currently has an “outperform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 12.48% from the stock’s previous close. The analysts noted that the move was a valuation call.
Several other equities research analysts also recently commented on HCA. Piper Jaffray Companies reaffirmed a “buy” rating and set a $92.00 target price on shares of HCA Healthcare in a report on Wednesday, October 4th. Mizuho reaffirmed a “buy” rating and set a $92.00 target price on shares of HCA Healthcare in a report on Wednesday, October 4th. Jefferies Group reaffirmed a “buy” rating and set a $92.00 target price on shares of HCA Healthcare in a report on Friday, October 13th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $95.00 target price on shares of HCA Healthcare in a report on Friday, October 13th. Finally, SunTrust Banks set a $90.00 target price on HCA Healthcare and gave the company a “buy” rating in a report on Sunday, October 15th. Four analysts have rated the stock with a sell rating, six have assigned a hold rating and seventeen have given a buy rating to the company’s stock. HCA Healthcare currently has an average rating of “Hold” and a consensus price target of $102.85.
Shares of HCA Healthcare (HCA) traded up $1.08 during mid-day trading on Thursday, reaching $102.24. The company had a trading volume of 3,192,172 shares, compared to its average volume of 2,553,019. HCA Healthcare has a fifty-two week low of $71.18 and a fifty-two week high of $106.84. The company has a market capitalization of $35,918.63, a PE ratio of 17.21, a P/E/G ratio of 1.14 and a beta of 0.55. The company has a debt-to-equity ratio of -6.58, a current ratio of 1.62 and a quick ratio of 1.41.
In related news, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the sale, the insider now directly owns 12,476 shares of the company’s stock, valued at approximately $973,128. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Victor L. Campbell sold 8,000 shares of the stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total value of $624,000.00. Following the completion of the sale, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at $9,927,450. The disclosure for this sale can be found here. Over the last three months, insiders sold 100,750 shares of company stock valued at $9,376,264. Company insiders own 2.90% of the company’s stock.
A number of institutional investors have recently made changes to their positions in the stock. Kovack Advisors Inc. purchased a new stake in shares of HCA Healthcare during the 4th quarter worth about $234,000. Victory Capital Management Inc. raised its stake in shares of HCA Healthcare by 11.8% during the 4th quarter. Victory Capital Management Inc. now owns 2,742,110 shares of the company’s stock worth $240,867,000 after purchasing an additional 288,758 shares in the last quarter. Highstreet Asset Management Inc. raised its stake in shares of HCA Healthcare by 47.6% during the 4th quarter. Highstreet Asset Management Inc. now owns 14,457 shares of the company’s stock worth $1,270,000 after purchasing an additional 4,660 shares in the last quarter. Northern Capital Management LLC raised its stake in shares of HCA Healthcare by 8.0% during the 4th quarter. Northern Capital Management LLC now owns 43,010 shares of the company’s stock worth $3,778,000 after purchasing an additional 3,170 shares in the last quarter. Finally, Twin Capital Management Inc. purchased a new stake in shares of HCA Healthcare during the 4th quarter worth about $1,605,000. 75.23% of the stock is owned by hedge funds and other institutional investors.
WARNING: “HCA Healthcare (HCA) Price Target Raised to $115.00 at BMO Capital Markets” was originally posted by American Banking and Market News and is the sole property of of American Banking and Market News. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/02/01/hca-healthcare-hca-price-target-raised-to-115-00-at-bmo-capital-markets.html.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
